QINGDAO, China, July 17, 2025 /PRNewswire/ — Haier, a world’s leading household appliances brand, announced that it has obtained the TV industry’s first European Accessibility Act (EAA) certificate for its LED TVs. This prestigious certification, awarded to Haier following a rigorous evaluation by DEKRA, encompasses a wide range of Haier’s smart LED TV products, including… Continue reading Haier TV Has Been Awarded the EU Accessibility Act Certificate by DEKRA — Marking the First Certificate of its Kind in the TV Industry
Category: Newswire
Guidehouse Research Estimates Global Market for Megawatt Charging Systems Will Reach Nearly $19 Billion by 2033
Market drivers include emissions reduction, government incentives, and cost BOULDER, Colo., July 17, 2025 /PRNewswire/ — A new report from Guidehouse Research evaluates the market for Megawatt Charging Systems (MCS) globally. Efforts to electrify medium- and heavy-duty vehicles (MHDVs) have focused on those with predictable routes and enough downtime to return to a depot for charging.… Continue reading Guidehouse Research Estimates Global Market for Megawatt Charging Systems Will Reach Nearly $19 Billion by 2033
SCU Brings Nation-Leading Chiropractic Program to Phoenix–A First for the Region
WHITTIER, Calif., July 17, 2025 /PRNewswire/ — Southern California University of Health Sciences (SCU) announced the expansion of its flagship Doctor of Chiropractic program to its Phoenix satellite campus, marking an historic first for the Southwestern U.S. region. With no other chiropractic programs currently operating in Arizona, New Mexico, Colorado, Wyoming, Idaho, Utah, or Nevada,… Continue reading SCU Brings Nation-Leading Chiropractic Program to Phoenix–A First for the Region
Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery
MILAN, July 17, 2025 /PRNewswire/ — A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination eye drop containing an anti-inflammatory steroid and a quinolone antibiotic, developed by NTC, indicated for the prevention and treatment of inflammation and prevention of infection following cataract surgery in adults. The study was submitted when… Continue reading Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery
Une étude de pharmacovigilance menée sur cinq ans par NTC confirme la sécurité des collyres à dose fixe pour la chirurgie de la cataracte
MILAN, 17 juillet 2025 /PRNewswire/ — Une étude de pharmacovigilance sur cinq ans récemment publiée confirme l’excellent profil de sécurité d’un collyre combiné à dose fixe contenant un stéroïde anti-inflammatoire et un antibiotique quinolone , développé par NTC, indiqué pour la prévention et le traitement de l’inflammation et la prévention de l’infection à la suite… Continue reading Une étude de pharmacovigilance menée sur cinq ans par NTC confirme la sécurité des collyres à dose fixe pour la chirurgie de la cataracte
Un estudio de NTC confirma la seguridad del colirio de combinación fija para la cirugía siguiente la catarata
Un estudio de farmacovigilancia de cinco años realizado por parte de NTC confirma la seguridad del colirio de combinación fija para la cirugía siguiente la catarata MILÁN, 17 de julio de 2025 /PRNewswire/ — Un estudio de farmacovigilancia de cinco años publicado recientemente confirma el excelente perfil de seguridad de un colirio de combinación fija que… Continue reading Un estudio de NTC confirma la seguridad del colirio de combinación fija para la cirugía siguiente la catarata
Fünfjährige Pharmakovigilanz-Studie von NTC bestätigt Sicherheit von fest dosierten Augentropfen nach Kataraktoperationen
MAILAND, 17. Juli 2025 /PRNewswire/ — Eine kürzlich veröffentlichte Fünf-Jahres-Pharmakovigilanzstudie bestätigt das ausgezeichnete Sicherheitsprofil eines von NTC entwickelten fest dosierten Kombinations-Augentropfens, der ein entzündungshemmendes Steroid und ein Chinolon-Antibiotikum enthält und zur Vorbeugung und Behandlung von Entzündungen und zur Vermeidung von Infektionen nach Kataraktoperationen bei Erwachsenen angezeigt ist. Die Studie wurde vorgelegt, als fast 4 Millionen Patienten… Continue reading Fünfjährige Pharmakovigilanz-Studie von NTC bestätigt Sicherheit von fest dosierten Augentropfen nach Kataraktoperationen
Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery
MILAN, July 17, 2025 /PRNewswire/ — A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination eye drop containing an anti-inflammatory steroid and a quinolone antibiotic, developed by NTC, indicated for the prevention and treatment of inflammation and prevention of infection following cataract surgery in adults. The study was submitted when… Continue reading Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery
Data Center Switch Front-End Networks Expand Rapidly to Keep Pace with AI Back-End Scale, According to Dell’Oro Group
More than 40 Percent CAGR in New AI Pull-Through Opportunities in Front-End Networks, Opening Doors for New and Existing Vendors REDWOOD CITY, Calif., July 17, 2025 /PRNewswire/ — According to a recently published report by Dell’Oro Group, the trusted source for information about the telecommunications, networks, and data center industries, the explosive scale in AI… Continue reading Data Center Switch Front-End Networks Expand Rapidly to Keep Pace with AI Back-End Scale, According to Dell’Oro Group
EIFO and the Novo Nordisk Foundation Acquire the World’s Most Powerful Quantum Computer
EIFO, the export and investment fund of Denmark, and the Novo Nordisk Foundation, an independent Danish enterprise foundation, are investing €80 million in the establishment of a new Nordic quantum initiative, QuNorth, to advance the region’s technological development. Microsoft and Atom Computing will bring to QuNorth the world’s most powerful quantum computer and the first… Continue reading EIFO and the Novo Nordisk Foundation Acquire the World’s Most Powerful Quantum Computer